Jeevandhara Medical Institute And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 11-01-2025
- Paid Up Capital ₹ 2.58 M
as on 11-01-2025
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 11.41%
(FY 2022)
- Profit -1568.08%
(FY 2022)
- Ebitda -35.47%
(FY 2022)
- Net Worth -25.14%
(FY 2022)
- Total Assets 4.76%
(FY 2022)
About Jeevandhara Medical Institute And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 2.58 M, as per Ministry of Corporate Affairs (MCA) records.
Annasaheb Patil, Dattatray Acharya, Rajkumar Malgave, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110PN2004PTC019165
- Company No.
019165
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2004
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jeevandhara Medical Institute And Research Centre?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Annasaheb Patil  | Whole-Time Director | 21-Apr-2004 | Current |
| Dattatray Acharya | Director | 18-Mar-2008 | Current |
| Rajkumar Malgave | Whole-Time Director | 30-Mar-2005 | Current |
| Sukumar Gat | Whole-Time Director | 21-Apr-2004 | Current |
Financial Performance of Jeevandhara Medical Institute And Research Centre.
Jeevandhara Medical Institute And Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 11.41% increase. The company also saw a substantial fall in profitability, with a 1568.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 25.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jeevandhara Medical Institute And Research Centre?
In 2021, Jeevandhara Medical Institute And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jeevandhara Medical Institute And Research Centre?
Unlock and access historical data on people associated with Jeevandhara Medical Institute And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jeevandhara Medical Institute And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jeevandhara Medical Institute And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
